This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Researchers Tie Cholesterol Levels in Women to Menstrual Cycle Phase
NIH Findings May Have Implications for Testing
By News Staff
Physicians testing a woman's cholesterol levels may need to take into account the phase of her menstrual cycle, according to a study published in the Journal of Clinical Endocrinology and Metabolism.
In a study of more than 250 women ages 18-44 years, researchers from the Eunice Kennedy Shriver National Institute of Child Health and Human Development -- which is part of the NIH -- found that HDL levels among the women studied rose in concert with estrogen levels, peaking at the time of ovulation.
Conversely, total cholesterol, LDL and triglyceride levels started to decline a few days after ovulation began and reached their lowest levels just before menstruation began.
The total cholesterol levels of the study's participants varied by nearly 20 percent during the course of their cycles.
Study co-author Erique Schisterman, Ph.D., said in a news release that when preliminary test results indicate high cholesterol, physicians often order a follow-up test for confirmation. Schisterman suggested that physicians could instead take one test at the end of a woman's cycle when cholesterol levels are low.
The researchers, however, acknowledged that further study could help clarify the optimal time for physicians to test a women's cholesterol levels.
Conversely, total cholesterol, LDL and triglyceride levels started to decline a few days after ovulation began and reached their lowest levels just before menstruation began.
The total cholesterol levels of the study's participants varied by nearly 20 percent during the course of their cycles.
Study co-author Erique Schisterman, Ph.D., said in a news release that when preliminary test results indicate high cholesterol, physicians often order a follow-up test for confirmation. Schisterman suggested that physicians could instead take one test at the end of a woman's cycle when cholesterol levels are low.
The researchers, however, acknowledged that further study could help clarify the optimal time for physicians to test a women's cholesterol levels.
Related ANN Coverage
AHRQ Releases New Clinician, Consumer Guides on Treating Hypercholesterolemia, Reducing Breast Cancer Risk
(4/27/2010)
FDA Warns of Risks Associated With Simvastatin
High Dose of Zocor, Use in Combination With Other Drugs Increase Risk of Muscle Injury
(3/24/2010)
News Briefs: FDA Approves Expanded Use of Crestor
(2/10/2010)
Additional Resource
CDC: Cholesterol
AHRQ Releases New Clinician, Consumer Guides on Treating Hypercholesterolemia, Reducing Breast Cancer Risk
(4/27/2010)
FDA Warns of Risks Associated With Simvastatin
High Dose of Zocor, Use in Combination With Other Drugs Increase Risk of Muscle Injury
(3/24/2010)
News Briefs: FDA Approves Expanded Use of Crestor
(2/10/2010)
Additional Resource
CDC: Cholesterol
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Clinical Care & Research
